RPGR and retinal degeneration: RPGR gene canine models (XLPRA1 and XLPRA2) have been treated with subretinal AAV2/5 full-length human RPGRex1-ORF15, with beneficial rescue of photoreceptor dysfunction to halt retinal degeneration [53].